In a remarkable display of scientific prowess, Senegal has emerged as a trailblazer in the fight against Rift Valley Fever (RVF), a viral disease with far-reaching implications for both animal and human health. This story is not just about a disease outbreak, but a testament to the power of advanced genomics and international collaboration.
The Challenge: A Threat to Livelihoods
When RVF struck Senegal in 2025, it posed a grave threat to the country's rural communities, where livestock farming is a cornerstone of the economy. The disease, which primarily affects cattle, sheep, and goats, can cause devastating losses and impact human health too. With an urgent need to control the outbreak, Senegal's health and veterinary authorities turned to innovative solutions.
A Breakthrough: Genomic Sequencing in Action
The National Livestock Laboratory and Veterinary Research Institute (LNERV) in Dakar played a pivotal role. With support from the International Atomic Energy Agency (IAEA) and its Zoonotic Disease Integrated Action (ZODIAC) initiative, LNERV scientists achieved a significant milestone: the first in-house whole genome sequencing of the RVF virus in Senegal. This advanced technology allowed them to identify the exact viral lineage, Lineage H, known for its efficient replication and association with major outbreaks.
The Impact of Rapid Genomic Characterization
Dr Assane Gueye Fall, Director of LNERV, emphasized the importance of rapid genomic characterization. It provides crucial information for targeted disease control measures and informed decision-making during outbreaks. The speed of analysis is a game-changer, significantly improving upon conventional diagnostic methods that often take much longer.
Building Regional Capacity: IAEA's Role
The IAEA's support extended beyond equipment and reagents. Scientists from LNERV underwent intensive training at the FAO/IAEA Animal Production and Health Laboratory in Austria, learning to operate advanced sequencing systems and analyze complex genomic data. This capacity-building effort has positioned LNERV as a leading veterinary laboratory in Africa with advanced pathogen sequencing capabilities.
Regional Collaboration: A Stronger Defense
Senegal's success has not only benefited its own outbreak response but has also extended to neighboring countries. Mauritania, which has experienced RVF outbreaks, now sends samples to Senegal for genomic analysis. This cross-border collaboration strengthens regional disease surveillance and enhances our understanding of how the virus spreads across West Africa. The Veterinary Laboratory Network (VETLAB) continues to provide essential support, ensuring a coordinated response.
A Model for Outbreak Preparedness
Experts highlight the growing importance of regional laboratories capable of rapid outbreak identification and pathogen characterization. Senegal's experience demonstrates the impact of investing in advanced scientific infrastructure, training, and international cooperation. By generating critical genetic information locally, scientists empower authorities to act swiftly, contain outbreaks effectively, and mitigate the risks posed by zoonotic diseases.
Conclusion: A Global Lesson
Senegal's story is a powerful reminder of the potential for scientific innovation to transform outbreak response. As we face increasing threats from emerging infectious diseases, the world can learn from Senegal's example, where advanced genomics and international collaboration have become a powerful defense against disease.
